Literature DB >> 29500627

Parkinson's Disease: Patients' Knowledge, Attitudes, and Interest in Genetic Counseling.

Kristin A Maloney1,2, Dina S Alaeddin3, Rainer von Coelln4, Shannan Dixon5, Lisa M Shulman4, Katrina Schrader4, Yue Guan6,7.   

Abstract

The objective of this study was to assess the genetics knowledge of patients with Parkinson's disease (PD), and to explore their attitudes on genetic testing and interest in genetic counseling. We surveyed 158 patients from the University of Maryland Parkinson's Disease and Movement Disorders Center. Patients averaged a score of 63% on general genetics knowledge and 73% on PD genetics knowledge. Participants had an overall positive attitude toward genetic testing: 80% believed that the use of genetic tests among people should be promoted, and 83% would undertake genetic test for PD if it was available. Patients reported a high interest to discuss the benefits, risks, and impacts of genetic testing for PD (mean sum score = 26, range = 9-35), and 43% patients expressed interest in meeting with a genetic counselor. Multivariate regression analysis showed that patients who had more positive attitudes toward genetic testing for PD were more interested in meeting with a genetic counselor (β = 0.6, p < 0.001). This study is the first to demonstrate an interest in genetic counseling among patients with PD. Our findings demonstrate a new niche for genetic counselors to support patients in clarifying gaps or misconceptions in knowledge about PD genetics as well as the possible risks, benefits, and limitations of genetic testing.

Entities:  

Keywords:  Attitudes; Genetic counseling; Genetic testing; Knowledge; Parkinson’s disease

Mesh:

Year:  2018        PMID: 29500627     DOI: 10.1007/s10897-018-0239-3

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  33 in total

1.  The Efficacy of Genetic Counseling for Psychiatric Disorders: a Meta-Analysis.

Authors:  Ramona Moldovan; Sebastian Pintea; Jehannine Austin
Journal:  J Genet Couns       Date:  2017-06-14       Impact factor: 2.537

Review 2.  Parkinson's disease.

Authors:  Lorraine V Kalia; Anthony E Lang
Journal:  Lancet       Date:  2015-04-19       Impact factor: 79.321

3.  Evaluating genetic counseling for family members of individuals with schizophrenia in the molecular age.

Authors:  Gregory Costain; Mary Jane Esplen; Brenda Toner; Kathleen A Hodgkinson; Anne S Bassett
Journal:  Schizophr Bull       Date:  2012-10-27       Impact factor: 9.306

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 5.  The genetic background of Parkinson's disease: current progress and future prospects.

Authors:  K Kalinderi; S Bostantjopoulou; L Fidani
Journal:  Acta Neurol Scand       Date:  2016-02-12       Impact factor: 3.209

6.  A family history of Parkinson's disease and its effect on other PD risk factors.

Authors:  B A Rybicki; C C Johnson; E L Peterson; G X Kortsha; J M Gorell
Journal:  Neuroepidemiology       Date:  1999       Impact factor: 3.282

Review 7.  Mendelian forms of Parkinson's disease.

Authors:  Thomas Gasser
Journal:  Biochim Biophys Acta       Date:  2009-01-06

8.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Authors:  Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton
Journal:  Nat Genet       Date:  2014-07-27       Impact factor: 38.330

9.  Knowledge and attitudes towards genetic testing: a two year follow-up study in patients with asthma, diabetes mellitus and cardiovascular disease.

Authors:  Hiske Calsbeek; Mattijn Morren; Jozien Bensing; Mieke Rijken
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.537

Review 10.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422

View more
  2 in total

1.  Genome Sequencing in the Parkinson Disease Clinic.

Authors:  Emily J Hill; Laurie A Robak; Rami Al-Ouran; Jennifer Deger; Jamie C Fong; Paul Jerrod Vandeventer; Emily Schulman; Sindhu Rao; Hiba Saade; Joseph M Savitt; Rainer von Coelln; Neeja Desai; Harshavardhan Doddapaneni; Sejal Salvi; Shannon Dugan-Perez; Donna M Muzny; Amy L McGuire; Zhandong Liu; Richard A Gibbs; Chad Shaw; Joseph Jankovic; Lisa M Shulman; Joshua M Shulman
Journal:  Neurol Genet       Date:  2022-06-09

Review 2.  Genetic Testing for Parkinson Disease: Are We Ready?

Authors:  Lola Cook; Jeanine Schulze; Catherine Kopil; Tara Hastings; Anna Naito; Joanne Wojcieszek; Katelyn Payne; Roy N Alcalay; Christine Klein; Rachel Saunders-Pullman; Tatyana Simuni; Tatiana Foroud
Journal:  Neurol Clin Pract       Date:  2021-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.